1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

0R1F.IL
Bristol-Myers Squibb CompanyGB flagInternational Order Book
65.75
USD
+1.90
- -
134.31BMarket Cap

Total Valuation

Bristol-Myers Squibb Company carries a market capitalization of 134.31B, placing it among publicly traded companies globally. Its enterprise value stands at 153.02B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap134.31B
Enterprise Value153.02B

Share Statistics

Bristol-Myers Squibb Company currently has 2.04B shares outstanding.

Shares Outstanding2.04B
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Bristol-Myers Squibb Company trades at a trailing price-to-earnings ratio of 12.80. The price-to-sales ratio is 2.42, and the price-to-book ratio stands at 5.33.

PE Ratio12.80
PS Ratio2.42
PB Ratio5.33
P/TBV Ratio-6.98
P/FCF Ratio9.33
P/OCF Ratio9.30

Enterprise Valuation

On an enterprise value basis, Bristol-Myers Squibb Company trades at an EV/EBITDA multiple of 8.99 and an EV/FCF ratio of 10.83. The EV/Sales ratio of 3.11 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.05 provides insight into valuation relative to core operating earnings.

EV / Sales3.11
EV / EBITDA8.99
EV / EBIT11.05
EV / FCF10.83

Financial Position

Bristol-Myers Squibb Company maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 201.86, indicating elevated leverage, while an interest coverage ratio of 9.84 demonstrates adequate ability to service its debt obligations.

Current Ratio1.53
Quick Ratio1.29
Debt / Equity201.86
Debt / EBITDA2.65
Interest Coverage9.84

Financial Efficiency

Bristol-Myers Squibb Company posts a return on equity of 46.70 and a return on invested capital of 15.90.

Return on Equity (ROE)46.70
Return on Assets (ROA)10.18
Return on Invested Capital (ROIC)15.90
Return on Capital Employed (ROCE)15.67
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover5.36

Taxes

Over the trailing twelve months, Bristol-Myers Squibb Company has paid 2.63B in income taxes, reflecting an effective tax rate of 22.12.

Income Tax2.63B
Effective Tax Rate22.12

Stock Price Statistics

Bristol-Myers Squibb Company's stock has gained approximately 35.09349% over the past 52 weeks. The 50-day moving average sits at 59.52, while the 200-day moving average is 57.08.

Beta (5Y)N/A
52-Week Price Change35.09349%
50-Day Moving Average59.52
200-Day Moving Average57.08
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Bristol-Myers Squibb Company generated 49.19B in revenue and converted that into 9.28B in net income, yielding earnings per share of 4.53. EBITDA reached 17.02B, while operating income came in at 13.84B.

Revenue49.19B
Gross Profit34.51B
Operating Income13.84B
Pretax Income11.91B
Net Income9.28B
EBITDA17.02B
EBIT13.84B
Earnings Per Share (EPS)4.53

Balance Sheet

Bristol-Myers Squibb Company holds 11.07B in cash and equivalents against 45.05B in total debt, resulting in a net debt position of 34.40B. Total book value stands at 22.32B, with working capital of 9.92B providing operational flexibility.

Cash & Cash Equivalents11.07B
Total Debt45.05B
Net Debt34.40B
Equity (Book Value)22.32B
Book Value Per Share10.93
Working Capital9.92B

Cash Flow

Bristol-Myers Squibb Company produced 12.78B in operating cash flow over the past twelve months.

Operating Cash Flow12.78B
Capital ExpendituresN/A
Free Cash Flow12.78B
FCF Per Share6.27

Margins

Bristol-Myers Squibb Company operates with a gross margin of 70.16, reflecting its pricing power and cost economics. The operating margin of 28.14 and net profit margin of 18.87 provide insight into operational efficiency.

Gross Margin70.16
Operating Margin28.14
Pretax Margin24.21
Profit Margin18.87
EBITDA Margin34.60

Dividends & Yields

The company's payout ratio of 54.98 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share2.50
Dividend YieldN/A
Payout Ratio54.98
Shareholder Yield9.84
FCF Yield10.72

Scores

Bristol-Myers Squibb Company posts an Altman Z-Score of 3.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.89